KU Leuven is Belgium's largest and highest-ranked university, consistently placed in the global top 50 (THE World Rankings) and number one in Europe for innovation (Reuters). Its Faculty of Medicine is one of the oldest in the world, tracing roots to 1425. The integrated medical curriculum spans seven years (three-year bachelor plus four-year master) and features early clinical contact from year one at the University Hospitals Leuven (UZ Leuven) — a 1,995-bed academic medical centre that is Belgium's largest hospital and a European reference centre for rare diseases, organ transplantation, and paediatric surgery.

Research output is extraordinary: KU Leuven's biomedical research generates more patent applications than any other European university, with breakthroughs in gene therapy, oncology, and neuroscience. The Rega Institute for Medical Research is world-famous for antiviral drug development. Leuven itself is a compact, bike-friendly medieval city with 100,000 students — one of Europe's highest student-to-resident ratios — creating an unmatched student atmosphere.

For UK students, tuition is remarkably affordable by Western European standards, the city is just two hours from London by train, and the degree is EU-recognised and GMC-registrable.